drugset / Trial / NCT00670800

Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome

NCT00670800 ↗

Completed 14 enrolled University of Michigan
Non-randomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the effects of insulin resistance on brain function in women with Polycystic Ovary Syndrome (PCOS). PCOS affected women will be evaluated prior to and following 4-month treatment with Metformin. Additionally, brain function in women with PCOS will be compared to the brain activity in normal control subjects with regular menstrual cycles.

Timeline

Start
2008-01
Primary completion
2009-08
Completion
2009-08

Outcome

Mixed primary results

registry MEAN PCOS Affected Women Pre-Metformin (Baseline): 2.40 (Standard Deviation .11) ratio NCT00670800 ↗

registry MEAN PCOS Affected Women Post-Metformin (After 4 Months): 2.11 (Standard Deviation 0.21) ratio NCT00670800 ↗

registry analysis (superiority or other test); PCOS Affected Women Pre-Metformin (Baseline) vs PCOS Affected Women Post-Metformin (After 4 Months); p = 0.038; t-test, 2 sided NCT00670800 ↗

registry analysis (superiority or other test); PCOS Affected Women Pre-Metformin (Baseline) vs PCOS Affected Women Post-Metformin (After 4 Months); p = 0.133; t-test, 2 sided NCT00670800 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral